Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | CNR1 | P21554 | 3/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.51 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.50 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6809424 | 1.00 | ALDH1A1 (0.68) | ALDH1A1MEN1KMT2APOLBKDM4E | |
| SCHEMBL13404404 | 0.87 | ALDH1A1 (0.58) | ALDH1A1MEN1KMT2APOLBKDM4E | |
| SCHEMBL13404394 | 0.86 | ALDH1A1 (0.57) | ALDH1A1MEN1KMT2APOLBKDM4E | |
| SCHEMBL27974779 | 0.84 | CNR1 (0.54) | ALDH1A1MEN1KMT2APOLBKDM4E | |
| SCHEMBL4395824 | 0.82 | MAPT (0.69) | ALDH1A1MEN1KMT2AUSP2CNR1 | |
| Hydrochloric Acid SCHEMBL17061716 | 0.81 | MAPT (0.67) | ALDH1A1MEN1KMT2AUSP2CNR1 | |
| SCHEMBL15010078 | 0.81 | ALDH1A1 (1.00) | ALDH1A1MEN1KMT2APOLBKDM4E | |
| SCHEMBL4555970 | 0.80 | ALDH1A1 (0.97) | ALDH1A1MEN1KMT2APOLBKDM4E | |
| SCHEMBL31684032 | 0.80 | ALDH1A1 (0.97) | ALDH1A1MEN1KMT2APOLBKDM4E | |
| SCHEMBL2705461 | 0.79 | L3MBTL1 (0.83) | ALDH1A1MEN1KMT2APOLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040132809-A1 | Cell adhesion inhibitors | BIOGEN, INC. | 2004-07-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132809-A1 | Cell adhesion inhibitors | VCAM1, ICAM1, EPCAM | ALDH1A1 631/4885MEN1 3126/4885KMT2A 2350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.